Regentis Biomaterials Ltd. (RGNT) stock
RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 24, 2026Score 1/30
$1.14−0.08 (-6.56%)
Close on Nov 18, 2026Market cap $5.90MP/E –Yield –
Regentis Biomaterials cash
Cash and short-term investments held at the end of each period.
Regentis Biomaterials's cash was $7.38M at Dec 31, 2025. For fiscal 2025 it was $7.38M.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.38M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $7.38M | – |
See a number that looks wrong?